Literature DB >> 15588974

What are the consequences of early rheumatoid arthritis for the individual?

David L Scott1, Claire Smith, Gabrielle Kingsley.   

Abstract

Rheumatoid arthritis (RA) has important impacts on health that can be related to the World Health Organization's new International Classification of Functioning, Disability and Health (ICF framework). The physical consequences of RA for the individual relate to body functions and structures in the ICF framework. The functional consequences of RA are related to activity in the ICF framework, and the impact of RA on society relates to participation in the ICF framework. Despite conventional treatment, early RA continues to result in significant physical consequences for most patients. From the patients' perspective, this primarily results from persistent pain, although symptoms such as fatigue and depression are also relevant. This is confirmed from the clinician's perspective by the infrequency of remission, persistence of disease activity and unrelenting radiographic progression in early RA. Patients with early RA often progress, within only a few years, to significant disability. This has mainly been shown in studies using the Health Assessment Questionnaire as the disability measure, although a small number of studies using generic health measures such as Short Form-36 have reached similar conclusions. RA patients and their friends and families incur the majority of costs associated with early RA. Many patients are not able to continue to work at the same level as they would have anticipated had they not developed RA. Later on, society bears an increased load, especially in patients with higher levels of disability; this results from major social care costs and interventions such as surgery. However, the evidence favouring expensive biological therapies, even in early RA, is likely to turn this analysis on its head in the near future.

Entities:  

Mesh:

Year:  2005        PMID: 15588974     DOI: 10.1016/j.berh.2004.08.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  23 in total

Review 1.  The patient's journey: rheumatoid arthritis.

Authors:  Carol Simpson; Chloe Franks; Catherine Morrison; Heidi Lempp
Journal:  BMJ       Date:  2005-10-15

2.  Use of spinal manipulation in a rheumatoid patient presenting with acute thoracic pain: a case report.

Authors:  Chadwick L R Chung; Silvano A Mior
Journal:  J Can Chiropr Assoc       Date:  2015-06

3.  Pain and difficulties performing valued life activities in women and men with rheumatoid arthritis.

Authors:  Inger Ahlstrand; Mathilda Björk; Ingrid Thyberg; Torbjörn Falkmer
Journal:  Clin Rheumatol       Date:  2015-01-25       Impact factor: 2.980

4.  Expectations of new treatment in rheumatoid arthritis: developing a patient-generated questionnaire.

Authors:  Darija Hofmann; Fowzia Ibrahim; Diana Rose; David L Scott; Andrew Cope; Til Wykes; Heidi Lempp
Journal:  Health Expect       Date:  2013-04-25       Impact factor: 3.377

5.  Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration.

Authors:  Chalotte Heinsvig Poulsen; Søren Jacobsen; Morten Frisch; Kirsten Frederiksen; Christoffer Johansen
Journal:  Rheumatol Int       Date:  2013-06-29       Impact factor: 2.631

6.  Implications of long-term conditions for both mental and physical health: comparison of rheumatoid arthritis and schizophrenia.

Authors:  Heidi Lempp; Graham Thornicroft; Morven Leese; Naomi Fearns; Helen Graves; Bernadette Khoshaba; Antonio Lasalvia; David Scott; Michele Tansella
Journal:  Qual Life Res       Date:  2009-05-10       Impact factor: 4.147

7.  Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/IkappaB kinase/nuclear factor kappaB pathway.

Authors:  Luciano Ottonello; Maria Bertolotto; Fabrizio Montecucco; Giordano Bianchi; Franco Dallegri
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

8.  Effects of Conventional and Biological Drugs Used for the Treatment of Rheumatoid Arthritis on the Quality of Life and Depression.

Authors:  Yakup Ilker Yayikci; Ahmet Karadag
Journal:  Eurasian J Med       Date:  2018-11-30

9.  Patients' experiences of living with and receiving treatment for fibromyalgia syndrome: a qualitative study.

Authors:  Heidi K Lempp; Stephani L Hatch; Serene F Carville; Ernest H Choy
Journal:  BMC Musculoskelet Disord       Date:  2009-10-07       Impact factor: 2.362

10.  Patients' views about treatment with combination therapy for rheumatoid arthritis: a comparative qualitative study.

Authors:  Heidi Lempp; Darija Hofmann; Stephani L Hatch; David L Scott
Journal:  BMC Musculoskelet Disord       Date:  2012-10-18       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.